Weissler, E. Hope http://orcid.org/0000-0002-8442-6150
Naumann, Tristan
Andersson, Tomas
Ranganath, Rajesh
Elemento, Olivier
Luo, Yuan
Freitag, Daniel F.
Benoit, James
Hughes, Michael C.
Khan, Faisal
Slater, Paul
Shameer, Khader
Roe, Matthew
Hutchison, Emmette
Kollins, Scott H.
Broedl, Uli
Meng, Zhaoling
Wong, Jennifer L.
Curtis, Lesley
Huang, Erich
Ghassemi, Marzyeh
Funding for this research was provided by:
Amgen Inc.
AstraZeneca
Bayer AG
Boehringer-Ingelheim
Cytokinetics
Eli Lilly & Company
Evidation
IQVIA
Janssen
Microsoft
Pfizer
Sanofi
Verily
Article History
Received: 30 April 2021
Accepted: 26 July 2021
First Online: 16 August 2021
Change Date: 6 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-021-05571-4
Declarations
:
: Not applicable.
: Not applicable.
: HW has nothing to disclose.TN has nothing to disclose.TA is an employee of AstraZeneca.RR has nothing to disclose.OE is a co-founder of and holds equity in OneThree Biotech and Volastra Therapeutics and is scientific advisor for and holds equity in Freenome and Owkin,YL has nothing to disclose.DF is an employee of Bayer AG, Germany.JB has nothing to disclose.MH reports personal fees from Duke Clinical Research Institute, non-financial support from RGI Informatics, LLC, and grants from Oracle Labs.FK is an employee of AstraZeneca.PS has nothing to disclose.SK is an employee of AstraZeneca; has served as an advisor for Kencor Health and OccamzRazor; has received consulting fees from Google Cloud (Alphabet), McKinsey, and LEK Consulting; was an employee of Philips Healthcare; and has a patent (Diagnosis and Classification of Left Ventricular Diastolic Dysfunction Using a Computer) issued to MSIP.Dr. Roe reports grants from the American College of Cardiology, American Heart Association, Bayer Pharmaceuticals, Familial Hypercholesterolemia Foundation, Ferring Pharmaceuticals, Myokardia, and Patient Centered Outcomes Research Institute; grants and personal fees from Amgen, AstraZeneca, and Sanofi Aventis; personal fees from Janssen Pharmaceuticals, Elsevier Publishers, Regeneron, Roche-Genetech, Eli Lilly, Novo Nordisk, Pfizer, and Signal Path; and is an employee of Verana Health.EH is an employee of AstraZeneca.SK reports personal fees from Holmusk.UB is an employee of Boehringer-Ingelheim.ZM has nothing to disclose.JW reports being an employee of Sanofi US.LC has nothing to disclose.EH reports personal fees from Valo Health and is a founder of (with equity in) kelaHealth and Clinetic.MG has nothing to disclose.